{"database": "lobbying", "table": "lobbying_activities", "rows": [[3801654, "ef160ad1-7d1a-40ec-b4ae-fa35eacb12ea", "Q1", "THE WASHINGTON TAX & PUBLIC POLICY GROUP", 294930, "REGENERON PHARMACEUTICALS, INC.", 2026, "first_quarter", "TAX", "Issues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, and 174.", null, 30000, null, 0, 0, "2026-04-01T13:15:25-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3801654"], "units": {}, "query_ms": 0.46880601439625025, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}